BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3156650)

  • 1. Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors.
    Erne P; Pletscher A
    Br J Pharmacol; 1985 Feb; 84(2):545-9. PubMed ID: 3156650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific inhibition of 5-HT-induced increase of intracellular free calcium by (+)- and (-)-desmethoxyverapamil in human platelets.
    Bruns C; Marmé D; Osswald H
    Br J Pharmacol; 1986 Mar; 87(3):481-2. PubMed ID: 3801761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-hydroxytryptamine receptor of blood platelets.
    Pletscher A; Affolter H
    J Neural Transm; 1983; 57(4):233-42. PubMed ID: 6655466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.
    Affolter H; Erne P; Bürgisser E; Pletscher A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):337-42. PubMed ID: 6427633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for different Ca2+ pools in the activation of rabbit platelets. I. release reaction and protein phosphorylation.
    Shaw JO; Lyons RM
    Biochim Biophys Acta; 1982 Feb; 714(3):492-9. PubMed ID: 6800409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between serotonin induced elevation of intracellular Ca2+ concentration and stimulation of Ca2+ influx in blood platelets.
    Nishio H; Ikegami Y; Nakata Y; Segawa T
    Neurochem Int; 1993 Feb; 22(2):205-10. PubMed ID: 8439773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
    De Clerck F; Xhonneux B; Leysen J; Janssen PA
    Thromb Res; 1984 Feb; 33(3):305-21. PubMed ID: 6710435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH.
    De Clerck F; Xhonneux B; Tollenaere JP; Janssen PA
    Thromb Res; 1985 Dec; 40(5):581-96. PubMed ID: 2935970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-(N,N-diethylamino)-n-octyl-3,4,5-trimethoxybenzoate reduced [Ca2+]i elevation induced by histamine, serotonin, and glutamate in cultured calf basilar artery smooth muscle cells.
    Wang B; Zhang XQ; Liu TP; Xiao JG
    Zhongguo Yao Li Xue Bao; 1998 May; 19(3):251-3. PubMed ID: 10375737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation by Ca2+ of platelet phospholipase A2. Effects of dibutyryl cyclic adenosine monophosphate and 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate.
    Rittenhouse-Simmons S; Deykin D
    Biochim Biophys Acta; 1978 Nov; 543(4):409-22. PubMed ID: 214141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors.
    Brazell C; McClue SJ; Preston GC; King B; Stahl SM
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):17-24. PubMed ID: 1772986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-induced vasoconstriction in dog kidney.
    Takahashi T; Hisa H; Satoh S
    J Cardiovasc Pharmacol; 1992; 20(5):779-84. PubMed ID: 1280741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
    de Clerck F; David JL; Janssen PA
    Agents Actions; 1982 Jul; 12(3):388-97. PubMed ID: 6215842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence digital image analysis of serotonin-induced calcium oscillations in single blood platelets.
    Nishio H; Ikegami Y; Segawa T
    Cell Calcium; 1991; 12(2-3):177-84. PubMed ID: 2059992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the intracellular calcium chelator Quin-2 on the platelet phosphoinositide metabolism, protein phosphorylation and morphology.
    de Chaffoy de Courcelles D; Roevens P; Verheyen F; Van Belle H; De Clerck F
    Thromb Haemost; 1987 Oct; 58(3):927-31. PubMed ID: 2829378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of contractile and relaxant 5-hydroxytryptamine receptors coupled to distinct signaling pathways in intestinal muscle cells: convergence of the pathways on Ca2+ mobilization.
    Kuemmerle JF; Martin DC; Murthy KS; Kellum JM; Grider JR; Makhlouf GM
    Mol Pharmacol; 1992 Dec; 42(6):1090-6. PubMed ID: 1336114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of extracellular Ca2+ and the intracellular Ca2+ antagonist 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate on rabbit platelet conversion of arachidonic acid into thromboxane.
    Shaw JO
    Prostaglandins; 1981 Apr; 21(4):571-9. PubMed ID: 6789402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors?
    Graf M; Pletscher A
    Br J Pharmacol; 1979 Apr; 65(4):601-8. PubMed ID: 435685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of calcium ion in platelet serotonin uptake regulation.
    Nishio H; Nezasa K; Nakata Y
    Eur J Pharmacol; 1995 Jan; 288(2):149-55. PubMed ID: 7720776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of protein kinase C activation by 8-(N,N-diethylamino)-octyl-3, 4, 5-trimethoxybenzoate (TMB-8), an intracellular Ca2+ antagonist.
    Sawamura M
    Kobe J Med Sci; 1985 Dec; 31(6):221-32. PubMed ID: 3831591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.